BCL2 and Parkinsonism: Madecassoside also exhibits similar properties, as seen in another study where the compound prevented early signs of Parkinsonism in MPTP‐treated rats by reversing the depletion of dopamine, upregulating antioxidant activity and increasing the Bcl‐2/Bax ratio.34